Search company, investor...

Investors Count

8

Funding, Valuation & Revenue

5 Fundings

Biochem Group's latest funding round was a Unattributed - II for on July 26, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/26/2018

Unattributed - II

$99M

0

FY undefined

2

7/10/2017

Unattributed

$99M

0

FY undefined

0

6/1/2017

Take Private

$99M

0

FY undefined

10

12/20/2016

IPO

$99M

0

FY undefined

10

12/17/2015

Private Equity

$99M

0

FY undefined

0

Date

7/26/2018

7/10/2017

6/1/2017

12/20/2016

12/17/2015

Round

Unattributed - II

Unattributed

Take Private

IPO

Private Equity

Amount

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

0

10

10

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Biochem Group Investors

8 Investors

Biochem Group has 8 investors. CEC Data Capital invested in Biochem Group's Unattributed - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/26/2018

7/26/2018

1
Unattributed - II

Corporate Venture

China

00/00/0000

00/00/0000

Tao Capital

Subscribe to see more

Venture Capital

China

00/00/0000

00/00/0000

Shunxi Fund

Subscribe to see more

Corporate Venture

China

00/00/0000

00/00/0000

Biochem Group

Subscribe to see more

Corporation

China

00/00/0000

00/00/0000

Orient Securities

Subscribe to see more

Investment Bank

China

First funding

7/26/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/26/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Tao Capital

Shunxi Fund

Biochem Group

Orient Securities

Rounds

1
Unattributed - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Corporate Venture

Corporation

Investment Bank

Location

China

China

China

China

China

Biochem Group Acquisitions

1 Acquisition

Biochem Group acquired 1 company. Their latest acquisition was Biochem Group on June 01, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/1/2017

Other

$99M

Take Private

1

Date

6/1/2017

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

Note

Take Private

Sources

1

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.